What is Prostate Brachytherapy?

Prostate brachytherapy is a minimally invasive treatment for localized prostate cancer that uses internal radiation to target cancer cells directly inside the prostate. Tiny radioactive seeds or temporary radiation sources are placed in the gland to deliver a high dose of radiation precisely where it’s needed, while minimizing exposure to surrounding organs such as the bladder and rectum.

This advanced procedure is performed at Busamed Gateway Private Hospital by Dr. Avikar Singh, a fellowship-trained urologist with expertise in uro-oncology and minimally invasive cancer treatment.

Benefits of Prostate Brachytherapy

• Highly targeted radiation with minimal damage to surrounding tissues
• Less invasive than surgery; no large incisions
• Typically an outpatient or short-stay procedure
• Quick recovery and return to normal activities
• Proven long-term cancer control for selected patients

Who is Suitable for Prostate Brachytherapy?

Prostate brachytherapy is most effective for men with:

• Localized prostate cancer that has not spread beyond the prostate
• Low- to intermediate-risk disease, based on PSA levels, biopsy results, and imaging
• A prostate size suitable for accurate placement of radioactive seeds
• A preference for a non-surgical, minimally invasive approach

Your urologist will evaluate your prostate size, cancer risk, and overall health to determine whether brachytherapy is a good treatment choice.

Procedure Overview

• Low-Dose Rate (LDR) Brachytherapy: Tiny radioactive seeds are permanently implanted in the prostate, releasing radiation over several months.
• High-Dose Rate (HDR) Brachytherapy: Temporary catheters deliver a high dose of radiation in short treatment sessions, and all sources are removed after treatment.
• Anaesthesia: General or spinal anaesthesia is used
• Duration: Typically 1–2 hours
• Hospital Stay: Day-case usually

Recovery and Follow-Up

Most patients can return to normal activities within a few days. Mild urinary symptoms such as frequency or discomfort are common but usually settle over time. Follow-up includes PSA monitoring and occasional imaging to ensure effective cancer control.